Humacyte, Inc. Increase (Decrease) in Due to Related Parties
Humacyte, Inc. (HUMA) reported Increase (Decrease) in Due to Related Parties of -$34.33 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2021-08-16
- Humacyte, Inc. increase (decrease) in due to related parties for the quarter ending 2021-06-30 was -$10.00K.
- Humacyte, Inc. increase (decrease) in due to related parties for the quarter ending 2021-03-31 was -$24.33K.
- Humacyte, Inc. increase (decrease) in due to related parties for the quarter ending 2020-12-31 was $30.00K.
- Humacyte, Inc. increase (decrease) in due to related parties for the quarter ending 2020-09-30 was $4.33K.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$34.33K 10-Q · filed 2021-08-16 | -$4.33K derived: sum of 3 quarters · filed 2021-08-16 | $0.00 derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | -$24.33K 10-Q · filed 2021-05-17 | $5.67K derived: sum of 2 quarters · filed 2021-05-17 | $10.00K derived: sum of 3 quarters · filed 2021-05-17 | |
| 2020-12-31 | $30.00K derived: 10-K/A 6 month − 10-Q 3 month · filed 2021-05-14 | $34.33K 10-K/A · filed 2021-05-14 | ||
| 2020-09-30 | $4.33K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |